Recombumin®: A Pharmaceutical Excipient In The Stabilization Of Therapeutic Protein Products
Source: Novozymes Biopharma US Inc.
Click Here To Download:
Presentation: Recombumin®: A Pharmaceutical Excipient In The Stabilization Of Therapeutic Protein Products
Presentation: Recombumin®: A Pharmaceutical Excipient In The Stabilization Of Therapeutic Protein Products
Presentation: Recombumin®: A Pharmaceutical Excipient In The Stabilization Of Therapeutic Protein Products
By Phuong Tran, Tatyana Mitina, Larissa Chirkova, Phil Morton, Darrell Sleep, Anthony Simula and Geoffrey Francis
Introduction
- Albumin has been used to stabilize APIs safely for many years
- Recombumin® (rAlbumin Human) is the world's first cGMP and animalfree recombinant human albumin.
- Purity >99%
- Homogeneous
- Stable; 5yr @ 2-8°C
- Batch-to-batch consistency
- Current applications:
- Manufacture of approved vaccines (FDA and EMEA)
- Drug-conjugation partner for short-lived peptides; successfully completed clinical phase II
Presentation: Recombumin®: A Pharmaceutical Excipient In The Stabilization Of Therapeutic Protein Products